2970
J. Bayardon, D. Sinou / Tetrahedron: Asymmetry 16 (2005) 2965–2972
added, and the methanol evaporated. The aqueous
phase was extracted with CHCl3 (3 · 20 mL), and the
chloroform solution was dried over Na2SO4. Evapora-
tion of the solvent under reduced pressure gave a residue
that was purified by column chromatography on silica
gel, using a 4:1 CH2Cl2/CH3OH mixture to give amino
alcohol 12 (650 mg, 88% yield) as a white solid. Mp
76–78 ꢁC [lit36 mp 77–79 ꢁC]; Rf 0.26 (CH2Cl2/CH3OH
Na2SO4. Evaporation of the solvent under reduced pres-
sure gave a residue that was purified by flash-chroma-
tography on silica gel, using ethyl acetate/petroleum
ether (2:1) as the eluent to give the fluorous bis(oxazo-
line) 14 (748 mg, 57% yield) as an oil. Rf 0.44 (petroleum
25
1
ether/ethyl acetate 2:1); ½a ¼ À9.7 (c 1.0, CHCl3); H
D
NMR (CDCl3): d 1.53–1.56 (m, 4H, CH2), 2.04–2.10
(m, 8H, CH2, CH2CF2), 2.60 (dd, J = 13.7, 8.3 Hz,
2H, CH2Ph), 3.30 (dd, J = 13.7, 4.9 Hz, 2H, CH2Ph),
3.98–4.02 (m, 2H, CH2O), 4.16–4.22 (m, 2H, CH2O),
4.37–4.40 (m, 2H, CHN), 4.49 (d, J = 5.1 Hz,
4H, OCH2–CH@), 5.26 (dd, J = 10.4, 1.3 Hz, 2H,
–CH@CH2), 5.39 (dd, J = 17.2, 1.3 Hz, 2H,
–CH@CH2), 5.98–6.10 (m, 2H, –CH@CH2), 6.84 (d,
J = 8.7 Hz, 4H, Harom), 7.10 (d, J = 8.7 Hz, 4H, Harom);
13C NMR (CDCl3): d 15.6, 31.3 (t, J = 21.0 Hz), 33.2,
40.9, 46.0, 67.7, 69.1, 72.2, 115.1, 117.8, 130.0, 130.7,
133.7, 157.7, 167.2; 19F NMR (CDCl3): d À127.0 (m,
4F, CF2), À124.2 (m, 4F, CF2), À123.5 (m, 4F, CF2),
À122.7 (m, 12F, CF2), À114.9 (m, 4F, CF2), À81.7 (t,
J = 9.3 Hz, 6F, CF3). Anal. Calcd for C49H40F34N2O4
(1366.8): C, 43.06; H, 2.95. Found: C, 43.08; H, 3.02.
25
1
4:1); ½a ¼ À14.5 (c 1, CHCl3); H NMR (300 MHz):
D
d 1.80 (br s, 3H, NH2, OH), 2.46 (dd, J = 13.6, 8.7 Hz,
1H, CH2Ph), 3.07 (dd, J = 13.6, 5.3 Hz, 1H, CH2Ph),
3.07 (m, 1H, CHN), 3.38 (dd, J = 10.5, 7.2 Hz, 1H,
CH2OH), 3.62 (dd, J = 10.5, 3.8 Hz, 1H, CH2OH),
4.51 (d, J = 5.3 Hz, 2H, OCH2), 5.27 (dd, J = 10.6,
1.5 Hz, 1H, CH@CH2), 5.41 (dd, J = 17.0, 1.5 Hz, 1H,
CH@CH2), 6.05 (m, 1H, CH@CH2), 6.85 (d,
J = 8.6 Hz, 2H, Harom), 7.10 (d, J = 8.6 Hz, 2H, Harom);
13C NMR (CDCl3): d 40.3, 54.6, 66.6, 69.2, 115.2, 118.0,
130.5, 131.2, 133.7, 157.6. HRMS: Calcd for
C12H18NO2 [M + H]+: 208.1338. Found: 208.1333.
4.12. (4S,40S)-2,20-Methylenebis[4-(4-allyloxybenzyl)-
4,5-dihydro-1,3-oxazole] 13
4.14. (4S,40S)-2,20-(1H,1H,2H,2H,3H,3H-Perfluoro-
tricosane-12,12-diyl)bis-[4-(4-hydroxy benzyl)-4,5-
dihydro-1,3-oxazole] 15
To amino alcohol 12 (700 mg, 3.38 mmol) dissolved in
CH2Cl2 (10 mL) was slowly added malonimidate ethyl
ester dihydrochloride (390 mg, 1.72 mmol). After being
stirred for 48 h at rt, water (10 mL) was added and the
organic product extracted with CH2Cl2 (3 · 10 mL).
The organic phase was washed with a saturated aqueous
solution of NaCl (20 mL), and dried over Na2SO4.
Evaporation of the solvent under reduced pressure gave
a residue that was purified by flash-chromatography on
silica gel, using ethyl acetate as the eluent to afford
A mixture of fluorous bis(oxazoline) 14 (770 mg,
0.56 mmol), Pd(OAc)2 (23.5 mg, 0.11 mmol), and PPh3
(130 mg, 0.50 mmol) in ethanol (10 mL) was refluxed
for 1.5 h. After cooling, SiO2 (1.13 g) was added and
the resulting mixture stirred for 45 min at rt. Filtration
over Celite followed by evaporation of the solvent gave
a residue that was purified by flash-chromatography on
silica gel, using ethyl acetate/petroleum ether (1:1) as the
eluent to give the fluorous bis(oxazoline) 15 (518 mg,
72% yield) as a yellow solid. Mp 67–69 ꢁC; Rf 0.6 (petro-
leum ether/ethyl acetate 1:1); [a]D = À19.3 (c 1.02, ace-
tone); 1H NMR (CD3COCD3): d 1.48–1.52 (m, 4H,
CH2), 1.89–1.95 (m, 4H, CH2), 2.06–2.19 (m, 4H,
CH2CF2), 2.46 (dd, J = 13.9, 7.6 Hz, 2H, CH2Ph), 2.73
(dd, J = 13.9, 6.0 Hz, 2H, CH2Ph), 3.80–3.86 (m, 2H,
CH2O), 4.05–4.11 (m, 2H, CH2O), 4.14–4.22 (m, 2H,
CHN), 6.62 (d, J = 8.6 Hz, 4H, Harom), 6.95 (d,
J = 8.6 Hz, 4H, Harom); 13C NMR (CD3COCD3): d
16.5, 31.8 (t, J = 22.0 Hz), 34.1, 41.8, 46.8, 68.7, 72.9,
116.3, 130.1, 131.6, 157.2, 167.7; 19F NMR
(CD3COCD3): d À126.6 (m, 4F, CF2), À123.9 (m, 4F,
CF2), À123.2 (m, 4F, CF2), À122.3 (m, 12F, CF2),
À114.6 (m, 4F, CF2), À81.2 (m, 6F, CF3). Anal. Calcd
for C43H32F34N2O4: C, 40.12; H, 2.51. Found: C,
40.32; H, 2.57.
bis(oxazoline) 13 (377 mg, 55% yield) as an oil. Rf 0.51
25
(CH2Cl2/CH3OH 9:1); ½a ¼ À16.9 (c 1.0, CHCl3);
D
1H NMR (CDCl3): d 2.62 (dd, J = 13.8, 8.3 Hz, 2H,
CH2Ph), 3.02 (dd, J = 13.8, 5.3 Hz, 2H, CH2Ph), 3.31
(s, 2H, CH2), 3.97–4.02 (m, 2H, CH2O), 4.19–4.25
(m, 2H, CH2O), 4.34–4.41 (m, 2H, CHN), 4.50
(d, J = 5.3 Hz, 4H, OCH2–CH@), 5.27 (dd, J = 10.5,
1.5 Hz, 2H, –CH@CH2), 5.39 (dd, J = 17.2, 1.5 Hz,
2H, –CH@CH2), 6.00–6.09 (m, 2H, –CH@CH2), 6.83
(d, J = 8.5 Hz, 4H, Harom), 7.10 (d, J = 8.5 Hz, 4H,
Harom); 13C NMR (CDCl3): d 28.8, 40.9, 67.9, 69.2,
72.6, 115.1, 118.0, 130.3, 130.6, 133.8, 157.7, 162.4.
Anal. Calcd for C27H30N2O4: C, 72.62; H, 6.77. Found:
C, 72.44; H, 6.84.
4.13. (4S,40S)-2,20-(1H,1H,2H,2H,3H,3H-Perfluorotric-
osane-12,12-diyl)bis[4-(4-allyloxy benzyl)-4,5-dihydro-
1,3-oxazole] 14
Bis(oxazoline) 13 (430 mg, 0.96 mmol) dissolved in
DMF (4 mL) was slowly added at 0 ꢁC to a suspension
of NaH (69 mg, 2.86 mmol) in dry DMF (8 mL). After
being stirred for 1 h at rt, C8F17(CH2)3I (1.29 g,
2.19 mmol) in DMF (4 mL) was slowly added. After
being stirred at 80 ꢁC for 16 h, half of the solvent was
evaporated, and water (10 mL) added. The organic
product was extracted using diethyl ether (4 · 10 mL),
and the ether solution was washed with a saturated
aqueous solution of NaCl (2 · 20 mL), and dried over
4.15. (4S,40S)-2,20-(1H,1H,2H,2H,3H,3H-Perfluorotric-
osane-12,12-diyl)bis-[4-(4-(1H,1H-perfluoroctyloxybenz-
yl))-4,5-dihydro-1,3-oxazole] 2
A mixture of bis(oxazoline) 15 (450 mg, 0.35 mmol),
pentadecafluorooctyl
nonafluorobutane
sulfonate
(610 mg, 0.90 mmol), and CsCO3 (380 mg, 1.17 mmol)
in dry DMF (7 mL) was stirred at 80 ꢁC for 18 h. After
cooling to rt, water (10 mL) was added, the aqueous
phase extracted with diethyl ether (3 · 10 mL), and the